People In The News

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Brian McNamee, a member of the board of directors at Gen-Probe, does not plan to stand for re-election to the position. Gen-Probe said in a filing with the US Securities and Exchange Commission that McNamee, who has served on its board on and off since 2002, decided to depart the board due to the demands of his position as CEO of CSL.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The US Food and Drug Administration has new guidelines that enable some gene and cell therapies to undergo expedited review, according to the New York Times.

Using gene drives to control invasive species might be too risky, an initial advocate of the approach says.

In Science this week: intellectual property experts argue patent battles such as the one over CRISPR are wasteful, and more.

Researchers have grown tumors in 3D cell cultures to better understand cancer, the Economist reports.